Selected research
Industry Growth & Trends
Global Obeticholic Acid Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Obeticholic Acid Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Obeticholic Acid Drug include Intercept Pharmaceuticals and Dainippon Sumitomo Pharma among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Obeticholic Acid Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Obeticholic Acid Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Obeticholic Acid Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Obeticholic Acid Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Obeticholic Acid Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Obeticholic Acid Drug Market by Company
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Obeticholic Acid Drug Segment by Type
5mg
10mg
Obeticholic Acid Drug Segment by Application
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
Obeticholic Acid Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obeticholic Acid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Obeticholic Acid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obeticholic Acid Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Obeticholic Acid Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Obeticholic Acid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
Applications
- Primary Biliary Cirrhosis
- Nonalcoholic Fatty Liver Disease
- Other
Companies covered
- Intercept Pharmaceuticals
- Dainippon Sumitomo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Obeticholic Acid Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Obeticholic Acid Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Obeticholic Acid Drug Market by Type
- 1.3.1 5mg
- 1.3.2 10mg
- 1.4 Global Obeticholic Acid Drug Market Size by Type
- 1.4.1 Global Obeticholic Acid Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Obeticholic Acid Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Obeticholic Acid Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Obeticholic Acid Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Obeticholic Acid Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Obeticholic Acid Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Obeticholic Acid Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Obeticholic Acid Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Obeticholic Acid Drug Industry Trends
- 2.2 Obeticholic Acid Drug Industry Drivers
- 2.3 Obeticholic Acid Drug Industry Opportunities and Challenges
- 2.4 Obeticholic Acid Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Obeticholic Acid Drug Revenue (2021-2026)
- 3.2 Global Top Players by Obeticholic Acid Drug Sales (2021-2026)
- 3.3 Global Top Players by Obeticholic Acid Drug Price (2021-2026)
- 3.4 Global Obeticholic Acid Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Obeticholic Acid Drug Major Company Production Sites & Headquarters
- 3.6 Global Obeticholic Acid Drug Company, Product Type & Application
- 3.7 Global Obeticholic Acid Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Obeticholic Acid Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Obeticholic Acid Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Obeticholic Acid Drug Tier 1, Tier 2, and Tier 3
4 Obeticholic Acid Drug Regional Status and Outlook
- 4.1 Global Obeticholic Acid Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Obeticholic Acid Drug Historic Market Size by Region
- 4.2.1 Global Obeticholic Acid Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Obeticholic Acid Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Obeticholic Acid Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Obeticholic Acid Drug Forecasted Market Size by Region
- 4.3.1 Global Obeticholic Acid Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Obeticholic Acid Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Obeticholic Acid Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Obeticholic Acid Drug by Application
- 5.1 Obeticholic Acid Drug Market by Application
- 5.1.1 Primary Biliary Cirrhosis
- 5.1.2 Nonalcoholic Fatty Liver Disease
- 5.1.3 Other
- 5.2 Global Obeticholic Acid Drug Market Size by Application
- 5.2.1 Global Obeticholic Acid Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Obeticholic Acid Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Obeticholic Acid Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Obeticholic Acid Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Obeticholic Acid Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Obeticholic Acid Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Obeticholic Acid Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Obeticholic Acid Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Intercept Pharmaceuticals
- 6.1.1 Intercept Pharmaceuticals Company Information
- 6.1.2 Intercept Pharmaceuticals Business Overview
- 6.1.3 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio
- 6.1.5 Intercept Pharmaceuticals Recent Developments
- 6.2 Dainippon Sumitomo Pharma
- 6.2.1 Dainippon Sumitomo Pharma Company Information
- 6.2.2 Dainippon Sumitomo Pharma Business Overview
- 6.2.3 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio
- 6.2.5 Dainippon Sumitomo Pharma Recent Developments
7 North America by Country
- 7.1 North America Obeticholic Acid Drug Sales by Country
- 7.1.1 North America Obeticholic Acid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Obeticholic Acid Drug Sales by Country (2021-2026)
- 7.1.3 North America Obeticholic Acid Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Obeticholic Acid Drug Market Size by Country
- 7.2.1 North America Obeticholic Acid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Obeticholic Acid Drug Market Size by Country (2021-2026)
- 7.2.3 North America Obeticholic Acid Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Obeticholic Acid Drug Sales by Country
- 8.1.1 Europe Obeticholic Acid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Obeticholic Acid Drug Sales by Country (2021-2026)
- 8.1.3 Europe Obeticholic Acid Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Obeticholic Acid Drug Market Size by Country
- 8.2.1 Europe Obeticholic Acid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Obeticholic Acid Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Obeticholic Acid Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Obeticholic Acid Drug Sales by Country
- 9.1.1 Asia-Pacific Obeticholic Acid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Obeticholic Acid Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Obeticholic Acid Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Obeticholic Acid Drug Market Size by Country
- 9.2.1 Asia-Pacific Obeticholic Acid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Obeticholic Acid Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Obeticholic Acid Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Obeticholic Acid Drug Sales by Country
- 10.1.1 South America Obeticholic Acid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Obeticholic Acid Drug Sales by Country (2021-2026)
- 10.1.3 South America Obeticholic Acid Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Obeticholic Acid Drug Market Size by Country
- 10.2.1 South America Obeticholic Acid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Obeticholic Acid Drug Market Size by Country (2021-2026)
- 10.2.3 South America Obeticholic Acid Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Obeticholic Acid Drug Sales by Country
- 11.1.1 Middle East and Africa Obeticholic Acid Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Obeticholic Acid Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Obeticholic Acid Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Obeticholic Acid Drug Market Size by Country
- 11.2.1 Middle East and Africa Obeticholic Acid Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Obeticholic Acid Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Obeticholic Acid Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Obeticholic Acid Drug Value Chain Analysis
- 12.1.1 Obeticholic Acid Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Obeticholic Acid Drug Production Mode & Process
- 12.2 Obeticholic Acid Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Obeticholic Acid Drug Distributors
- 12.2.3 Obeticholic Acid Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst